DUBLIN, December 07, 2021--(BUSINESS WIRE)--The "Peripheral Arterial Disease (PAD) Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at US$776.4 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 4.7% over the period 2020-2027.
The U.S. Market is Estimated at $228.7 Million, While China is Forecast to Grow at 4.4% CAGR
The Peripheral Arterial Disease (PAD) Therapeutics market in the U.S. is estimated at US$228.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$189.1 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.
Select Competitors (Total 23 Featured):
Bayer HealthCare Pharmaceuticals
Bristol-Myers Squibb Company
Merck & Co., Inc.
Proteon Therapeutics, Inc.
Symic Bio, Inc.
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
PAD - A Prelude
Recent Market Activity
Critical Limb Ischemia - An Insight
High Costs - A Cause of Concern
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Aging - A Key Driver
High Diabetes Incidence Worldwide: Key Market Opportunity for PAD Therapeutics
4. GLOBAL MARKET PERSPECTIVE
For more information about this report visit https://www.researchandmarkets.com/r/8tqgxu
View source version on businesswire.com: https://www.businesswire.com/news/home/20211207005520/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900